Legacy-Oriented Interventions for Supporting Family Bereavement and Psychosocial Adaptation in Pediatric Palliative Care: A Systematic Review.

Am J Hosp Palliat CareSep 24, 2025 (epub)
Clinical ResearchPediatricsPsychiatry

Daniela Jesus-Ferreira, Paulo Reis-Pina

✦ AI-curated · Sources linked

In 30 seconds

This systematic review assessed legacy-oriented interventions (LOI) for children and families receiving pediatric palliative care. It included nine qualitative studies from the United States, involving 164 participants; eight studies were rated high quality and one moderate. Across the studies, LOI supported emotional connection with the child, coping and meaning-making, and ongoing relationships with healthcare professionals. Effects varied according to whether the legacy was tangible or intangible and the family’s stage of bereavement. Evidence on symptom control and broader social outcomes was limited.

Key findings

  • Nine qualitative studies from the United States included 164 participants; eight were rated high quality and one moderate.
  • LOI supported emotional connection with the child, coping, meaning-making, and sustained relationships with healthcare professionals.
  • Reported effects varied by legacy type—tangible or intangible—and by the family’s stage of bereavement.
  • Few studies examined symptom control or broader social outcomes.

Why it matters

Legacy-oriented activities may help families maintain emotional bonds and adapt to grief during pediatric palliative care. The review also highlights that these interventions can be adapted to cultural or spiritual contexts. However, the evidence is qualitative and geographically limited, so the findings offer insight into potential psychosocial value rather than a firm estimate of effectiveness.

What to keep in mind

The evidence comprised small qualitative studies, all conducted in the United States; few examined symptom control or broader social outcomes.

Source

Published in Am J Hosp Palliat Care. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Pediatrics

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.